Teladoc (TDOC) Outperforms Broader Market: What You Need to Know
Werte in diesem Artikel
The latest trading session saw Teladoc (TDOC) ending at $7.40, denoting a +1.79% adjustment from its last day's close. The stock's change was more than the S&P 500's daily gain of 0.09%.The telehealth services provider's stock has climbed by 2.25% in the past month, exceeding the Medical sector's gain of 2.17% and lagging the S&P 500's gain of 7.21%.The upcoming earnings release of Teladoc will be of great interest to investors. The company is predicted to post an EPS of -$0.23, indicating a 17.86% growth compared to the equivalent quarter last year. In the meantime, our current consensus estimate forecasts the revenue to be $621.92 million, indicating a 3.19% decline compared to the corresponding quarter of the prior year.For the full year, the Zacks Consensus Estimates project earnings of -$1.17 per share and a revenue of $2.51 billion, demonstrating changes of +80.07% and -2.15%, respectively, from the preceding year.Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Teladoc. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Therefore, positive revisions in estimates convey analysts' confidence in the company's business performance and profit potential.Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an 8.56% increase. Currently, Teladoc is carrying a Zacks Rank of #3 (Hold).The Medical Services industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 68, which puts it in the top 28% of all 250+ industries.The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.Zacks Names #1 Semiconductor StockIt's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Teladoc Health, Inc. (TDOC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Teladoc und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Teladoc
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Teladoc
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Teladoc Inc
Analysen zu Teladoc Inc
Datum | Rating | Analyst | |
---|---|---|---|
02.11.2018 | Teladoc Buy | Chardan Capital Markets | |
03.08.2018 | Teladoc Buy | Chardan Capital Markets | |
05.06.2018 | Teladoc Buy | Canaccord Adams | |
15.03.2018 | Teladoc Hold | Deutsche Bank AG | |
28.02.2018 | Teladoc Buy | Chardan Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
02.11.2018 | Teladoc Buy | Chardan Capital Markets | |
03.08.2018 | Teladoc Buy | Chardan Capital Markets | |
05.06.2018 | Teladoc Buy | Canaccord Adams | |
28.02.2018 | Teladoc Buy | Chardan Capital Markets | |
08.12.2017 | Teladoc Buy | Deutsche Bank AG |
Datum | Rating | Analyst | |
---|---|---|---|
15.03.2018 | Teladoc Hold | Deutsche Bank AG | |
18.09.2017 | Teladoc Neutral | Robert W. Baird & Co. Incorporated |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Teladoc Inc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen